{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:47:31Z","timestamp":1788871651452,"version":"build-2803163510"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T00:00:00Z","timestamp":1399507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"crossref","award":["CONACYT-132353"],"award-info":[{"award-number":["CONACYT-132353"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"crossref","award":["214RT0482"],"award-info":[{"award-number":["214RT0482"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007774","name":"Instituto de Ciencia y Tecnolog\u00eda del Distrito Federal","doi-asserted-by":"crossref","award":["ICyTDF-45\/2012"],"award-info":[{"award-number":["ICyTDF-45\/2012"]}],"id":[{"id":"10.13039\/100007774","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007774","name":"Instituto de Ciencia y Tecnolog\u00eda del Distrito Federal","doi-asserted-by":"crossref","award":["PIRIVE09-9"],"award-info":[{"award-number":["PIRIVE09-9"]}],"id":[{"id":"10.13039\/100007774","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Secretar\u00eda de Investigaci\u00f3n y Posgrado\/Comisi\u00f3n de Operaci\u00f3n y Fomento de Actividades Acad\u00e9micas del Instituto Polit\u00e9cnico Nacional","award":["SIP\/COFAA-IPN-20130379"],"award-info":[{"award-number":["SIP\/COFAA-IPN-20130379"]}]},{"name":"Secretar\u00eda de Investigaci\u00f3n y Posgrado\/Comisi\u00f3n de Operaci\u00f3n y Fomento de Actividades Acad\u00e9micas del Instituto Polit\u00e9cnico Nacional","award":["20140252"],"award-info":[{"award-number":["20140252"]}]},{"name":"CONACyT"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.bcp.2014.04.016","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T15:46:25Z","timestamp":1399045585000},"page":"145-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Structural and energetic analysis to provide insight residues of CYP2C9, 2C11 and 2E1 involved in valproic acid dehydrogenation selectivity"],"prefix":"10.1016","volume":"90","author":[{"given":"Martiniano","family":"Bello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Mendieta-Wejebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Correa-Basurto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2014.04.016_bib0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: past, present and future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev"},{"issue":"2","key":"10.1016\/j.bcp.2014.04.016_bib0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/03602530903401658","article-title":"Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective","volume":"42","author":"Tang","year":"2010","journal-title":"Drug Metab Rev"},{"issue":"3","key":"10.1016\/j.bcp.2014.04.016_bib0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1517\/17425255.3.3.407","article-title":"Drug metabolite profiling and elucidation of drug-induced hepatotoxicity","volume":"3","author":"Tang","year":"2007","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"10.1016\/j.bcp.2014.04.016_bib0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0090-9556(25)08733-1","article-title":"The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes","volume":"17","author":"Porubek","year":"1989","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.bcp.2014.04.016_bib0025","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/tx600351g","article-title":"Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expression","volume":"20","author":"Leone","year":"2007","journal-title":"Chem Res Toxicol"},{"issue":"9","key":"10.1016\/j.bcp.2014.04.016_bib0030","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1124\/dmd.109.027797","article-title":"A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding","volume":"37","author":"Nakayama","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.bcp.2014.04.016_bib0035","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/03602530600959433","article-title":"Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity","volume":"38","author":"Chang","year":"2006","journal-title":"Drug Metab Rev"},{"issue":"2","key":"10.1016\/j.bcp.2014.04.016_bib0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Tavares de Almeida I valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review","volume":"31","author":"Silva","year":"2008","journal-title":"J Inherit Metab Dis"},{"issue":"27","key":"10.1016\/j.bcp.2014.04.016_bib0045","doi-asserted-by":"crossref","first-page":"13733","DOI":"10.1016\/S0021-9258(18)68302-4","article-title":"Cytochrome P-450-catalyzed desaturation of valproic acid in vitro: species differences, induction effects, and mechanistic studies","volume":"263","author":"Rettie","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.04.016_bib0050","author":"Ortiz de Montellano","year":"1995"},{"key":"10.1016\/j.bcp.2014.04.016_bib0055","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/ja00007a057","article-title":"Valproic acid metabolism by cytochrome P450: a theoretical study of stereoelectronic modulators of product distribution","volume":"113","author":"Collins","year":"1991","journal-title":"J Am Chem Soc"},{"issue":"12","key":"10.1016\/j.bcp.2014.04.016_bib0060","first-page":"1599","article-title":"Mechanism of cytochrome P4503A4- and 2D6-catalyzed dehydrogenation of ezlopitant as probed with isotope effects using five deuterated analogs","volume":"29","author":"Obach","year":"2001","journal-title":"Drug Metab Dispos"},{"issue":"41","key":"10.1016\/j.bcp.2014.04.016_bib0065","doi-asserted-by":"crossref","first-page":"9011","DOI":"10.1021\/bi101139q","article-title":"Improved cytochrome P450 3A4 molecular models accurately predict the Phe215 requirement for raloxifene dehydrogenation selectivity","volume":"49","author":"Moore","year":"2010","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.bcp.2014.04.016_bib0070","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0090-9556(25)08874-9","article-title":"An unusual metabolite of testosterone 17 beta-hydroxy-4,6-androstadien-3-one","volume":"14","author":"Nagata","year":"1986","journal-title":"Drug Metab Dispos"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2014.04.016_bib0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0009-2797(97)00145-2","article-title":"Cytochrome P450-dependent desaturation of lauric acid: isoform selectivity and mechanism of formation of 11-dodecenoic acid","volume":"110","author":"Guan","year":"1998","journal-title":"Chem Biol Interact"},{"issue":"5","key":"10.1016\/j.bcp.2014.04.016_bib0080","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/096032719601500512","article-title":"CYP enzymes catalyze the formation of a terminal olefin from 2-ethylhexanoic acid in rat and human liver","volume":"15","author":"Pennanen","year":"1996","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.bcp.2014.04.016_bib0085","author":"Ortiz de Montellano","year":"1986"},{"issue":"5","key":"10.1016\/j.bcp.2014.04.016_bib0090","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1021\/cr00081a015","article-title":"Cytochrome P450 and chloroperoxidase: thiolate-ligated heme enzymes spectroscopic determination of their active-site structures and mechanistic implications of thiolate ligation","volume":"87","author":"Dawson","year":"1987","journal-title":"Chem Rev"},{"issue":"7","key":"10.1016\/j.bcp.2014.04.016_bib0095","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1021\/cr9500500","article-title":"Heme-containing oxygenases","volume":"96","author":"Sono","year":"1996","journal-title":"Chem Rev"},{"key":"10.1016\/j.bcp.2014.04.016_bib0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/3-540-61388-9_62","article-title":"Cytochrome P450: significance, reaction mechanisms and active site analogues","volume":"184","author":"Woggon","year":"1997","journal-title":"Bioorg Chem: Top Curr Chem"},{"issue":"4","key":"10.1016\/j.bcp.2014.04.016_bib0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/b101297p","article-title":"Oxidizing species in the mechanism of cytochrome P450","volume":"19","author":"Ortiz de Montellano","year":"2002","journal-title":"Nat Prod Rep"},{"issue":"8","key":"10.1016\/j.bcp.2014.04.016_bib0110","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s007750100278","article-title":"Alternatives to the oxoferryl porphyrin cation radical as the proposed reactive intermediate of cytochrome P450: two-electron oxidized Fe(III) porphyrin derivatives","volume":"6","author":"Watanabe","year":"2001","journal-title":"J Biol Inorg Chem"},{"issue":"6","key":"10.1016\/j.bcp.2014.04.016_bib0115","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1021\/cr0307143","article-title":"Structure and chemistry of cytochrome P450","volume":"105","author":"Denisov","year":"2005","journal-title":"Chem Rev"},{"issue":"9","key":"10.1016\/j.bcp.2014.04.016_bib0120","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1021\/cr020443g","article-title":"Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes","volume":"104","author":"Meunier","year":"2004","journal-title":"Chem Rev"},{"issue":"16","key":"10.1016\/j.bcp.2014.04.016_bib0125","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1021\/ja0318737","article-title":"Oxygen economy of cytochrome P450: what is the origin of the mixed functionality as a dehydrogenase\u2013oxidase enzyme compared with its normal function?","volume":"126","author":"Kumar","year":"2004","journal-title":"J Am Chem Soc"},{"issue":"37","key":"10.1016\/j.bcp.2014.04.016_bib0130","doi-asserted-by":"crossref","first-page":"9756","DOI":"10.1021\/bi8005658","article-title":"Single mutations change CYP2F3 from a dehydrogenase of 3-methylindole to an oxygenase","volume":"47","author":"Kartha","year":"2008","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.bcp.2014.04.016_bib0135","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.0306-5251.2001.01474.x","article-title":"In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9)","volume":"52","author":"Wen","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"18","key":"10.1016\/j.bcp.2014.04.016_bib0140","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1046\/j.1432-1033.2003.03739.x","article-title":"Key substrate recognition residues in the active site of a plant cytochrome P450, CYP73A1. Homology guided site-directed mutagenesis","volume":"270","author":"Schoch","year":"2003","journal-title":"Eur J Biochem"},{"issue":"26","key":"10.1016\/j.bcp.2014.04.016_bib0145","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0024-3205(97)00717-0","article-title":"Use of homology modeling in conjunction with site-directed mutagenesis for analysis of structure\u2013function relationships of mammalian cytochromes P450","volume":"61","author":"Szklarz","year":"1997","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.bcp.2014.04.016_bib0150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0887-2333(02)00132-7","article-title":"Homology modelling of CYP2A6 based on the CYP2C5 crystallographic template: enzyme-substrate interactions and QSARs for binding affinity and inhibition","volume":"17","author":"Lewis","year":"2003","journal-title":"Toxicol In Vitro"},{"issue":"6","key":"10.1016\/j.bcp.2014.04.016_bib0155","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/00498250410001691325","article-title":"Homology modelling of CYP3A4 from the CYP2C5 crystallographic template: analysis of typical CYP3A4 substrate interactions","volume":"34","author":"Lewis","year":"2004","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.bcp.2014.04.016_bib0160","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1124\/dmd.108.022707","article-title":"Dehydrogenation of the indoline-containing drug 4-chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (indapamide) by CYP3A4: correlation with in silico predictions","volume":"37","author":"Sun","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"14","key":"10.1016\/j.bcp.2014.04.016_bib0165","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/jm0300330","article-title":"Information decay in molecular docking screens against holo, apo, and modeled conformations of enzymes","volume":"46","author":"McGovern","year":"2003","journal-title":"J Med Chem"},{"issue":"11","key":"10.1016\/j.bcp.2014.04.016_bib0170","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat Rev Drug Discovery"},{"issue":"4","key":"10.1016\/j.bcp.2014.04.016_bib0175","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bcp.2009.04.020","article-title":"Evaluation of the binding orientations of testosterone in the active site of homology models for CYP2C11 and CYP2C13","volume":"78","author":"Wang","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.bcp.2014.04.016_bib0180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00894-009-0547-5","article-title":"Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis","volume":"16","author":"Cassidy","year":"2010","journal-title":"J Mol Model"},{"issue":"5","key":"10.1016\/j.bcp.2014.04.016_bib0185","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.chemosphere.2010.04.043","article-title":"Computational studies of interactions between endocrine disrupting chemicals and androgen receptor of different vertebrate species","volume":"80","author":"Wu","year":"2010","journal-title":"Chemosphere"},{"issue":"7","key":"10.1016\/j.bcp.2014.04.016_bib0190","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1517\/17460441.2013.794780","article-title":"Automated docking for novel drug discovery","volume":"8","author":"Bello","year":"2013","journal-title":"Expert Opin Drug Discovery"},{"issue":"7","key":"10.1016\/j.bcp.2014.04.016_bib0195","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00894-010-0881-7","article-title":"Docking and molecular dynamics study on the inhibitory activity of N,N-disubstituted-trifluoro-3-amino-2-propanols-based inhibitors of cholesteryl ester transfer protein","volume":"17","author":"Dong","year":"2011","journal-title":"J Mol Model"},{"issue":"1","key":"10.1016\/j.bcp.2014.04.016_bib0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00894-009-0521-2","article-title":"Probing ligand binding modes of Mycobacterium tuberculosis MurC ligase by molecular modeling, dynamics simulation and docking","volume":"16","author":"Anuradha","year":"2010","journal-title":"J Mol Model"},{"issue":"4","key":"10.1016\/j.bcp.2014.04.016_bib0205","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tiv.2012.01.020","article-title":"A new approach on valproic acid induced hepatotoxicity: involvement of lysosomal membrane leakiness and cellular proteolysis","volume":"26","author":"Pourahmad","year":"2012","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"10.1016\/j.bcp.2014.04.016_bib0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0009-9120(01)00217-X","article-title":"CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity","volume":"34","author":"Neuman","year":"2001","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.bcp.2014.04.016_bib0215","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0022-3565(24)37076-4","article-title":"Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acid","volume":"283","author":"Sadeque","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.bcp.2014.04.016_bib0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/07391102.1994.10508088","article-title":"Application of 3-dimensional homology modeling of cytochrome P450 2B1 for interpretation of site-directed mutagenesis results","volume":"12","author":"Szklarz","year":"1994","journal-title":"J Biomol Struct Dyn"},{"issue":"23","key":"10.1016\/j.bcp.2014.04.016_bib0225","doi-asserted-by":"crossref","first-page":"10728","DOI":"10.1016\/S0021-9258(18)67446-0","article-title":"Hormonal regulation of rat liver microsomal enzymes role of gonadal steroids in programming, maintenance, and suppression of delta 4-steroid 5 alpha-reductase, flavin-containing monooxygenase, and sex-specific cytochromes P-450","volume":"261","author":"Dannan","year":"1986","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.bcp.2014.04.016_bib0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0925-4439(91)90034-7","article-title":"Age-dependent expression of cytochrome P-450s in rat liver","volume":"1097","author":"Imaoka","year":"1991","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.bcp.2014.04.016_bib0235","first-page":"109","article-title":"Influence of stress and dexamethasone on plasma levels of antiepileptic drugs and theophylline in rats","volume":"13","author":"Danilczuk","year":"2010","journal-title":"Ann Univ Mariae Curie Sklodowska"},{"issue":"21","key":"10.1016\/j.bcp.2014.04.016_bib0240","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","article-title":"Clustal W and Clustal X version 2.0","volume":"23","author":"Larkin","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bcp.2014.04.016_bib0245","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2105-9-40","article-title":"I-TASSER server for protein 3D structure prediction","volume":"9","author":"Zhang","year":"2008","journal-title":"BMC Bioinf"},{"issue":"33","key":"10.1016\/j.bcp.2014.04.016_bib0250","doi-asserted-by":"crossref","first-page":"W289","DOI":"10.1093\/nar\/gki390","article-title":"PRALINE: a multiple sequence alignment toolbox that integrates homology-extended and secondary structure information","volume":"1","author":"Simossis","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"10.1016\/j.bcp.2014.04.016_bib0255","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bcp.2014.04.016_bib0260","unstructured":"ISIS\/Draw, MDL Information System, 14600 Catalina Street, San Leandro, CA 94677, USA. The program (editions of 2.5 and 2.3) is available at the MDL at http:\/\/www.mdli.com\/downloads\/isisdraw.html (Accessed January 10, 2013)."},{"key":"10.1016\/j.bcp.2014.04.016_bib0265","unstructured":"WebLab Viewer, available at http:\/\/www.liv.ac.uk\/ctichem\/16weblab.html (Accessed January 20, 2013)."},{"key":"10.1016\/j.bcp.2014.04.016_bib0270","series-title":"Th\u00e8se no. 2561","article-title":"Development of the molecular graphics package MOLEKEL and its application to selected problems in organic and organometallic chemistry","author":"Fl\u00fckiger","year":"1992"},{"key":"10.1016\/j.bcp.2014.04.016_bib0275","unstructured":"HyperChem (TM) Professional 6.0. Gainesville, FL, USA: Hypercube Inc.; 1985."},{"key":"10.1016\/j.bcp.2014.04.016_bib0280","series-title":"Gaussian 03, revision A.1","author":"Frisch","year":"2003"},{"key":"10.1016\/j.bcp.2014.04.016_bib0285","series-title":"AMBER 12","author":"Case","year":"2012"},{"issue":"12","key":"10.1016\/j.bcp.2014.04.016_bib0290","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F","article-title":"How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?","volume":"21","author":"Wang","year":"2000","journal-title":"J Comput Chem"},{"issue":"9","key":"10.1016\/j.bcp.2014.04.016_bib0295","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general Amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bcp.2014.04.016_bib0300","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcc.10128","article-title":"Fast, efficient generation of high-quality atomic charges AM1-BCC model: II. Parameterization and validation","volume":"23","author":"Jakalian","year":"2002","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bcp.2014.04.016_bib0305","unstructured":"Amber Parameter Database: http:\/\/www.pharmacy.manchester.ac.uk\/bryce\/amber (Accessed March 13, 2013)."},{"issue":"2","key":"10.1016\/j.bcp.2014.04.016_bib0310","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J Chem Phys"},{"issue":"12","key":"10.1016\/j.bcp.2014.04.016_bib0315","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N-log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys"},{"issue":"5","key":"10.1016\/j.bcp.2014.04.016_bib0320","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/00268977700102571","article-title":"Algorithm for macromolecular dynamics and constraint dynamics","volume":"34","author":"Van Gunsteren","year":"1977","journal-title":"Mol Phys"},{"issue":"8","key":"10.1016\/j.bcp.2014.04.016_bib0325","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J Chem Phys"},{"key":"10.1016\/j.bcp.2014.04.016_bib0330","series-title":"The PyMOL molecular graphics system","author":"DeLano","year":"2002"},{"key":"10.1016\/j.bcp.2014.04.016_bib0335","doi-asserted-by":"crossref","first-page":"19824","DOI":"10.1021\/jp961710n","article-title":"Parameterized models of aqueous free energies of solvation based on pairwise descreening of solute atomic charges from a dielectric medium","volume":"100","author":"Hawkins","year":"1996","journal-title":"J Phys Chem"},{"key":"10.1016\/j.bcp.2014.04.016_bib0340","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1021\/jm000241h","article-title":"Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models","volume":"43","author":"Kuhn","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2014.04.016_bib0345","unstructured":"ROCS, Version 2.2. Santa Fe, NM: Openeye Scientific Software; 1997, http:\/\/www.eyesopen.com."},{"key":"10.1016\/j.bcp.2014.04.016_bib0350","series-title":"Version 2.1.2: Openeye Scientific Software","author":"FRED","year":"2005"},{"issue":"4","key":"10.1016\/j.bcp.2014.04.016_bib0355","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/jm7009793","article-title":"Prediction of metabolism by cytochrome P450 2C9: alignment and docking studies of a validated database of substrates","volume":"51","author":"Sykes","year":"2008","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.bcp.2014.04.016_bib0360","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1021\/ci4004688","article-title":"DR-predictor: incorporating flexible docking with specialized electronic reactivity and machine learning techniques to predict CYP-mediated sites of metabolism","volume":"53","author":"Huang","year":"2013","journal-title":"J Chem Inf Model"},{"issue":"4","key":"10.1016\/j.bcp.2014.04.016_bib0365","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/prot.20389","article-title":"Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins","volume":"58","author":"Kirton","year":"2005","journal-title":"Proteins"},{"issue":"5","key":"10.1016\/j.bcp.2014.04.016_bib0370","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/med.20067","article-title":"Combining docking and molecular dynamic simulations in drug design","volume":"26","author":"Alonso","year":"2006","journal-title":"Med Res Rev"},{"issue":"1","key":"10.1016\/j.bcp.2014.04.016_bib0375","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/prot.20951","article-title":"Multiple molecular dynamics simulations of human p450 monooxygenase CYP2C9: the molecular basis of substrate binding and regioselectivity toward warfarin","volume":"64","author":"Seifert","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.bcp.2014.04.016_bib0380","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbagen.2006.07.005","article-title":"The ins and outs of cytochrome P450s","volume":"1770","author":"Cojocaru","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"34","key":"10.1016\/j.bcp.2014.04.016_bib0385","doi-asserted-by":"crossref","first-page":"35630","DOI":"10.1074\/jbc.M405427200","article-title":"The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0\u2014a resolution","volume":"279","author":"Wester","year":"2004","journal-title":"J Biol Chem"},{"issue":"27","key":"10.1016\/j.bcp.2014.04.016_bib0390","doi-asserted-by":"crossref","first-page":"8165","DOI":"10.1021\/jp800311c","article-title":"Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences","volume":"112","author":"Skopal\u00edk","year":"2008","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.bcp.2014.04.016_bib0395","first-page":"1","article-title":"Studies on 16\u03b1-hydroxylation of steroid molecules and regioselective binding mode in homology-modeled cytochrome P450-2C11","volume":"918168","author":"Hamed","year":"2011","journal-title":"Intern J Med Chem"},{"key":"10.1016\/j.bcp.2014.04.016_bib0400","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.str.2007.10.007","article-title":"A Voronoi diagram based explorer of molecular channels, pores, and tunnels","volume":"15","author":"Petrek","year":"2007","journal-title":"Structure"},{"issue":"39","key":"10.1016\/j.bcp.2014.04.016_bib0405","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1021\/ja0524604","article-title":"Thermal equilibrium of high-and low-spin forms of cytochrome P450 BM-3: repositioning of the substrate?","volume":"127","author":"Jovanovic","year":"2005","journal-title":"J Am Chem Soc"},{"issue":"3","key":"10.1016\/j.bcp.2014.04.016_bib0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0033500","article-title":"Investigation of indazole unbinding pathways in CYP2E1 by molecular dynamics simulations","volume":"7","author":"Shen","year":"2012","journal-title":"PLoS One"},{"issue":"48","key":"10.1016\/j.bcp.2014.04.016_bib0415","doi-asserted-by":"crossref","first-page":"33698","DOI":"10.1074\/jbc.M805999200","article-title":"Structures of human cytochrome P-450 2E1 Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates","volume":"283","author":"Porubsky","year":"2008","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bcp.2014.04.016_bib0420","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/prot.24260","article-title":"\u03c0\u2013\u03c0 stacking mediated drug-drug interactions in human CYP2E1","volume":"81","author":"Liu","year":"2013","journal-title":"Proteins"},{"issue":"4","key":"10.1016\/j.bcp.2014.04.016_bib0425","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1124\/mol.59.4.909","article-title":"Competitive CYP2C9 inhibitors: enzyme inhibition studies, protein homology modeling, and three-dimensional quantitative structure-activity relationship analysis","volume":"59","author":"Afzelius","year":"2001","journal-title":"Mol Pharmacol"},{"issue":"12","key":"10.1016\/j.bcp.2014.04.016_bib0430","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1016\/j.ejmech.2010.09.008","article-title":"Investigating the structural basis of arylamides to improve potency against M. tuberculosis strain through molecular dynamics simulations","volume":"45","author":"Punkvang","year":"2010","journal-title":"Eur J Med Chem"},{"issue":"49","key":"10.1016\/j.bcp.2014.04.016_bib0435","doi-asserted-by":"crossref","first-page":"10458","DOI":"10.1021\/bi101577p","article-title":"Insights into nucleotide recognition by cell division protein FtsZ from a mant-GTP competition assay and molecular dynamics","volume":"49","author":"Schaffner-Barbero","year":"2010","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bcp.2014.04.016_bib0440","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0169-409X(02)00009-1","article-title":"Pharmacophore modeling of cytochromes P450","volume":"54","author":"De Groot","year":"2002","journal-title":"Adv Drug Delivery Rev"},{"issue":"13\u201314","key":"10.1016\/j.bcp.2014.04.016_bib0445","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.drudis.2006.05.001","article-title":"Designing better drugs: predicting cytochrome P450 metabolism","volume":"11","author":"De Groot","year":"2006","journal-title":"Drug Discovery Today"},{"issue":"1","key":"10.1016\/j.bcp.2014.04.016_bib0450","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0003-9861(02)00548-9","article-title":"Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid","volume":"409","author":"Melet","year":"2003","journal-title":"Arch Biochem Biophys"},{"issue":"10","key":"10.1016\/j.bcp.2014.04.016_bib0455","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1021\/bi062320m","article-title":"Ensemble modeling of substrate binding to cytochromes P450: analysis of catalytic differences between CYP1A orthologs","volume":"46","author":"Prasad","year":"2007","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.bcp.2014.04.016_bib0460","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1016\/j.biortech.2010.12.021","article-title":"A combined approach of experiments and computational docking simulation to the Coprinus cinereus peroxidase-catalyzed oxidative polymerization of alkyl phenols","volume":"102","author":"Park","year":"2011","journal-title":"Bioresour Technol"},{"issue":"1","key":"10.1016\/j.bcp.2014.04.016_bib0465","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1097-2765(00)80408-6","article-title":"Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity","volume":"5","author":"Williams","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2014.04.016_bib0470","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214002585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214002585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:20:40Z","timestamp":1746192040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295214002585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0006295214002585"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2014.04.016","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural and energetic analysis to provide insight residues of CYP2C9, 2C11 and 2E1 involved in valproic acid dehydrogenation selectivity","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2014.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}